Week44, 2020
1. Influenza activity remains low nationwide, with respiratory specimens testing positive for influenza at a rate of 0.1%.
2. Of the 21 positive specimens reported by clinical labs, 61.9% were Influenza A and 38.1% were Influenza B.
3. Public health labs reported only 17 positive specimens, with 29.4% being Influenza A and 70.6% Influenza B; the only subtype characterized was the Victoria lineage for Influenza B.
4. Outpatient visits for influenza-like illness (ILI) accounted for 1.3% of visits, a slight increase from last week but still below the national baseline of 2.6%.
5. No pediatric deaths were reported for the 2020-21 season, though one associated with Influenza B from the previous season was belatedly reported.
6. Pneumonia, influenza, or COVID-19 (PIC) accounted for 8.1% of deaths, surpassing the epidemic threshold of 6.0%.
7. Virologic testing and hospitalization rates will be updated later in the season, as specimen numbers and reporting increase.
8. CDC urges individuals to get annual influenza vaccination; no significant vaccination trends were reported in this summary.
9. Healthcare-seeking for ILI remains impacted by alternative care settings during the COVID-19 pandemic, which limits traditional data interpretation.
10. Future flu activity remains unpredictable due to changing healthcare behaviors and the simultaneous tracking of COVID-19 trends.